{
  "docId": "019de073-ffd7-72cc-99b5-ba07531f6cb6",
  "docSlug": "a123f40e9330b868ab1ae4e6c7ad8e46",
  "documentTitle": "Invitae | Results Presentation Deck | 28 slides",
  "authorId": "invitae",
  "authorName": "Invitae",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 9,
  "pageCount": 28,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "key_messages",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 2,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-ffd7-72cc-99b5-ba07531f6cb6/9",
  "deckHref": "/decks/019de073-ffd7-72cc-99b5-ba07531f6cb6",
  "deckJsonHref": "/decks/019de073-ffd7-72cc-99b5-ba07531f6cb6.json",
  "deckAnchorHref": "/decks/019de073-ffd7-72cc-99b5-ba07531f6cb6#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.28,
        "x": 0.05,
        "y": 0.175
      },
      "kind": "list",
      "text": "Oncology: Hereditary Cancer (Market leader, Guideline expansion, Call point growth to non-experts); Somatic (Massive growth, $20-30B TAM MRD, Proprietary tech, Traction in pharma market)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7f86aa31-91b2-4640-bc0f-37c72c4e6393",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.28,
        "x": 0.67,
        "y": 0.175
      },
      "kind": "list",
      "text": "Rare & Data: Unique multi-sided platform; Growth momentum; Recent wins, RareDx and patient network pairing; Transformation underway",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ee6fa105-ed96-480f-8029-6fde43f67ad2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.28,
        "x": 0.36,
        "y": 0.175
      },
      "kind": "list",
      "text": "Women's health: Margin (+) and APT expansion; Fast growing, $2.5B TAM; Cross-selling opportunities and product enhancements",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f608f5ee-06fa-456b-8d73-85b04ffd91fb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.3,
        "x": 0.35,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "Notes: 1. JP Morgan, 2022 Life Science and Diagnostics Outlook. 2. Based on Company estimates.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "30c981a6-6e1f-4d39-b01c-d0aa6ee2843e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Multiple growth and margin initiatives underway",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "064aab70-ecad-42c7-83b9-44f6918b87cd",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "ccb2b5c8-abc6-4bd6-a8be-4215834f47e1",
      "evidence": "The slide contains a list/bullet with multiple items, indicating a list presentation.",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}